newsfilter
← Latest News
Business Wire·

2seventy bio Reiterates Commitment to Maximizing Shareholder Value

2seventy bio, Inc. (NASDAQ:TSVT), ("2seventy" or "the Company"), a leading immuno-oncology cell therapy company, today issued the following statement reiterating its commitment to maximizing shareholder value: As we